Czapska, Mirella, Kamila Babkiewicz, Szczepan Pabis, and Katarzyna Skórzyńska-Dziduszko. “Sotagliflozin, an Inhibitor of sodium–glucose Cotransporters 1 and 2 (SGLT1 2), As a New Therapeutic Approach for Patients With Type 1 Diabetes Mellitus”. Journal of Education, Health and Sport 8, no. 12 (December 14, 2018): 335–351. Accessed December 23, 2025. https://apcz.umk.pl/JEHS/article/view/6378.